iCAD to Present at America’s Growth Capital 6th Annual East Coast Emerging Growth Conference | iCAD, Inc.
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News iCAD, Inc. iCAD to Present at America’s Growth Capital 6th Annual East Coast Emerging Growth Conference

iCAD to Present at America’s Growth Capital 6th Annual East Coast Emerging Growth Conference

Company News - iCAD, Inc.

iCAD announces to Present at America’s Growth Capital 6th Annual East Coast Emerging Growth Conference on October 7, 2009

iCAD , Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announced that Ken Ferry, President and Chief Executive Officer and Darlene Deptula-Hicks, Executive Vice President and Chief Financial Officer, will be presenting a corporate update at America’s Growth Capital’s 6th Annual East Coast Emerging Growth Conference on October 7, 2009 at 9:50 a.m. (Eastern time) being held at The Westin Copley Place in Boston.

Management will also be available for one-on-one meetings with investors participating in America’s Growth Capital’s 6th Annual East Coast Emerging Growth Conference. For those who would like to schedule an appointment with iCAD management, please contact Anne Marie Fields, Lippert/Heilshorn & Associates, Inc., at 212-838-3777 or at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or contact your America’s Growth Capital representative.

About iCAD , Inc.

iCAD , Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR)), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Since receiving FDA approval for the Company’s first breast cancer detection product in 2002, over 3,200 iCAD systems have been placed in healthcare practices worldwide. iCAD’s solutions aid in the early detection of the most prevalent cancers including breast, prostate and in the future, colon and lung cancer. For more information, call (877) iCADnow or visit www.icadmed.com.

Source: iCAD , Inc.

You can discuss about iCAD , Inc. and its products & services in the iCAD , Inc. Company User Group